Dina A. Moustafa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dina A. Moustafa has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Joanna B. Goldberg
Department of Pediatrics, Division of Pulmonary, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine
14 shared publications - Marvin Whiteley
Center for Microbial Dynamics and Infection, School of Biological Sciences, Georgia Institute of Technology
4 shared publications Frances L. Diggle
Emory-Children’s Cystic Fibrosis Center
3 shared publications- Gina R. Lewin
Center for Global Health and Diseases, Department of Pathology, Case Western Reserve University School of Medicine
3 shared publications - Rebecca P. Duncan
Department of Biology, University of Miami, Coral Gables, FL 33146
3 shared publications Ananya Kapur
Department of Microbiology and Molecular Genetics, University of Pittsburgh
2 shared publications
Latest Publications
- Open Access
- 8 September 2026
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 94 (9)
Growing Staphylococcus aureus in synthetic cystic fibrosis medium promotes colonization in a murine pneumonia model
Staphylococcus aureus is a leading cause of bacterial infections worldwide and can lead to diseases, such as osteomyelitis, skin, and lung infections in humans. Murine infection models have been an essential tool to the study of S. aureus virulence, although they do have their limitations. In murine pneumonia models, S. aureus infections are generally not well maintained. We hypothesize that culturing S. aureus under different conditions, such as in Synthetic CF Medium 2 (SCFM2), would increase bacterial respiratory loads compared to growing the bacteria on standard rich medium agar plates. We observed that culturing six S. aureus strains from various sources in SCFM2 resulted in a neutral or increased level of bacterial lung load compared with those cultured on agar plates. Focusing on one strain, WU1, we found that culturing in SCFM2 improved bacterial persistence in the oropharynx and led to a sustained long-term lung infection compared with agar plates. We further noted that mice experienced increased inflammation in both lobes of the lungs when infected with WU1 cultured in SCFM2 compared with agar plates. Overall, we have shown that culturing S. aureus under different conditions prior to infection impacts the level of colonization and host response.
- 8 September 2026
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 94 (9)
Open AccessGrowing Staphylococcus aureus in synthetic cystic fibrosis medium promotes colonization in a murine pneumonia model
Staphylococcus aureus is a leading cause of bacterial infections worldwide and can lead to diseases, such as osteomyelitis, skin, and lung infections in humans. Murine infection models have been an essential tool to the study of S. aureus virulence, although they do have their limitations. In murine pneumonia models, S. aureus infections are generally not well maintained. We hypothesize that culturing S. aureus under different conditions, such as in Synthetic CF Medium 2 (SCFM2), would increase bacterial respiratory loads compared to growing the bacteria on standard rich medium agar plates. We observed that culturing six S. aureus strains from various sources in SCFM2 resulted in a neutral or increased level of bacterial lung load compared with those cultured on agar plates. Focusing on one strain, WU1, we found that culturing in SCFM2 improved bacterial persistence in the oropharynx and led to a sustained long-term lung infection compared with agar plates. We further noted that mice experienced increased inflammation in both lobes of the lungs when infected with WU1 cultured in SCFM2 compared with agar plates. Overall, we have shown that culturing S. aureus under different conditions prior to infection impacts the level of colonization and host response.
- Open Access
- 27 January 2026
- Published by American Society for Microbiology in mSphere
- Vol. 11 (1) , e0065725
Whole-tissue imaging reveals intrastrain diversity shapes the spatial organization of Pseudomonas aeruginosa in a murine infection model
Intrastrain genetic and phenotypic heterogeneity of Pseudomonas aeruginosa is a hallmark of chronic lung infections in individuals with cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). Although the coexistence of multiple P. aeruginosa lineages within a single host is well documented, the impact of this heterogeneity on infection microbiogeography remains poorly understood. We previously showed that loss of the lipopolysaccharide (LPS) O-specific antigen (OSA) alters P. aeruginosa aggregate assembly. Since OSA-deficient variants are common in chronic pulmonary infections and associated with increased pathogenesis and immune evasion, we investigated whether intrastrain OSA diversity shapes infection microbiogeography. We constructed mixed populations containing equal ratios of OSA-deficient variants and wild-type (WT) cells and examined aggregate assembly and population structures in a synthetic CF sputum model (SCFM2). To assess OSA heterogeneity in vivo , we used a murine pneumonia model combined with hybridization chain reaction (HCR) RNA-FISH and whole-tissue clearing to visualize spatial organization in the airways. In SCFM2, OSA-deficient variants increased total population size, reduced WT aggregate size, and altered spatial organization. We employed 2-plex HCR RNA-FISH to distinguish WT and OSA-deficient variants in murine lungs. Interestingly, in contrast to in vitro conditions, OSA-deficient cells led to significantly larger WT aggregates in the airways. These findings highlight the role of intrastrain genetic heterogeneity in shaping infection microbiogeography and provide a framework for understanding how population dynamics influence microbial physiology and host-pathogen interactions at the micron scale. IMPORTANCE: Intrastrain genetic and phenotypic diversity within Pseudomonas aeruginosa populations is common in chronic pulmonary infections. While this intrastrain heterogeneity is a hallmark of chronic infection, its consequences for the spatial organization of P. aeruginosa within the airways remain unclear. Here, we demonstrate that the loss of O-specific antigen in a subpopulation of P. aeruginosa significantly alters the spatial architecture of P. aeruginosa , without changing the total population size or composition. Using a combination of tissue clearing and hybridization chain reaction RNA-FISH in a murine lung infection model, we mapped the localization of genetically distinct P. aeruginosa variants in mixed populations in vivo . These findings reveal that genetic diversification within a strain can reshape the infection landscape at the micron scale, highlighting the overlooked role of intrastrain dynamics in shaping the microbiogeography of infections and influencing host-pathogen interactions.
- 27 January 2026
- Published by American Society for Microbiology in mSphere
- Vol. 11 (1) , e0065725
Open AccessWhole-tissue imaging reveals intrastrain diversity shapes the spatial organization of Pseudomonas aeruginosa in a murine infection model
Intrastrain genetic and phenotypic heterogeneity of Pseudomonas aeruginosa is a hallmark of chronic lung infections in individuals with cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). Although the coexistence of multiple P. aeruginosa lineages within a single host is well documented, the impact of this heterogeneity on infection microbiogeography remains poorly understood. We previously showed that loss of the lipopolysaccharide (LPS) O-specific antigen (OSA) alters P. aeruginosa aggregate assembly. Since OSA-deficient variants are common in chronic pulmonary infections and associated with increased pathogenesis and immune evasion, we investigated whether intrastrain OSA diversity shapes infection microbiogeography. We constructed mixed populations containing equal ratios of OSA-deficient variants and wild-type (WT) cells and examined aggregate assembly and population structures in a synthetic CF sputum model (SCFM2). To assess OSA heterogeneity in vivo , we used a murine pneumonia model combined with hybridization chain reaction (HCR) RNA-FISH and whole-tissue clearing to visualize spatial organization in the airways. In SCFM2, OSA-deficient variants increased total population size, reduced WT aggregate size, and altered spatial organization. We employed 2-plex HCR RNA-FISH to distinguish WT and OSA-deficient variants in murine lungs. Interestingly, in contrast to in vitro conditions, OSA-deficient cells led to significantly larger WT aggregates in the airways. These findings highlight the role of intrastrain genetic heterogeneity in shaping infection microbiogeography and provide a framework for understanding how population dynamics influence microbial physiology and host-pathogen interactions at the micron scale. IMPORTANCE: Intrastrain genetic and phenotypic diversity within Pseudomonas aeruginosa populations is common in chronic pulmonary infections. While this intrastrain heterogeneity is a hallmark of chronic infection, its consequences for the spatial organization of P. aeruginosa within the airways remain unclear. Here, we demonstrate that the loss of O-specific antigen in a subpopulation of P. aeruginosa significantly alters the spatial architecture of P. aeruginosa , without changing the total population size or composition. Using a combination of tissue clearing and hybridization chain reaction RNA-FISH in a murine lung infection model, we mapped the localization of genetically distinct P. aeruginosa variants in mixed populations in vivo . These findings reveal that genetic diversification within a strain can reshape the infection landscape at the micron scale, highlighting the overlooked role of intrastrain dynamics in shaping the microbiogeography of infections and influencing host-pathogen interactions.
- Open Access
- 12 December 2025
- Published by Oxford University Press (OUP) in FEMS Microbiology Reviews
- Vol. 50
Developing antisense oligomer biotics “asobiotics” as precision antibacterials: designs, strategies, and considerations for future success
Antimicrobial resistance poses a pressing global health challenge in the 21st century. The rapid increase and prevalence of multidrug-resistant bacteria will require novel approaches to develop new antibiotics. Major advances in nucleic acid-based therapeutics, particularly antisense technologies, could be one solution for developing precision antibiotics. The selectivity and specificity in the drug design of antibacterial antisense oligomers (ASOs) allows precise gene-specific silencing and ultimately enables targeting of currently undruggable gene products. Our goal here is to comprehensively review the advances in asobiotics (antisense oligomer biotics) leading to therapeutic success, including modifications in the nucleic acid backbone of ASOs, which have improved their properties and progresses in delivery. We will discuss utilization of ASOs against several pathogens, strategies to overcome resistance, and finally future scenarios and prospects for asobiotics as pathogen-specific therapy in the clinic.
- 12 December 2025
- Published by Oxford University Press (OUP) in FEMS Microbiology Reviews
- Vol. 50
Open AccessDeveloping antisense oligomer biotics “asobiotics” as precision antibacterials: designs, strategies, and considerations for future success
Antimicrobial resistance poses a pressing global health challenge in the 21st century. The rapid increase and prevalence of multidrug-resistant bacteria will require novel approaches to develop new antibiotics. Major advances in nucleic acid-based therapeutics, particularly antisense technologies, could be one solution for developing precision antibiotics. The selectivity and specificity in the drug design of antibacterial antisense oligomers (ASOs) allows precise gene-specific silencing and ultimately enables targeting of currently undruggable gene products. Our goal here is to comprehensively review the advances in asobiotics (antisense oligomer biotics) leading to therapeutic success, including modifications in the nucleic acid backbone of ASOs, which have improved their properties and progresses in delivery. We will discuss utilization of ASOs against several pathogens, strategies to overcome resistance, and finally future scenarios and prospects for asobiotics as pathogen-specific therapy in the clinic.
- Open Access
- 1 July 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (7) , e0281124
piv does not impact Pseudomonas aeruginosa virulence in Galleria mellonella
Pseudomonas aeruginosa is an opportunistic human pathogen that can also infect mammals, invertebrates, and plants. Protease IV (PIV) is a secreted protease shown to be important in mammalian cornea, lung, and wound models of infection. It also contributes to P. aeruginosa virulence in many invertebrate models. Previous studies have shown that the expression of the gene encoding PIV is higher at 25°C than at 37°C. Thus, we hypothesized that piv would be more important for P. aeruginosa virulence at 25°C than at 37°C. To test this, we first demonstrated that more PIV is secreted by P. aeruginosa PAO1 cells grown at 25°C than at 37°C. We then determined the survival of larvae of the greater wax moth Galleria mellonella infected by PAO1 and an isogenic Δ piv mutant at both 25°C and 37°C. We found no significant difference in virulence between PAO1 and Δ piv at either 25°C or 37°C, although both strains were more virulent at 37°C than 25°C as measured by a decrease in median survival time. P. aeruginosa possesses an arsenal of virulence factors besides PIV, and thus loss of this single virulence factor may not result in attenuation in the highly susceptible G. mellonella larvae. IMPORTANCE: Pathogenesis of the important opportunistic pathogen Pseudomonas aeruginosa is often investigated using model organisms. Larvae of the greater wax moth, Galleria mellonella , are a popular non-mammalian model organism for P. aeruginosa infections that have been used to study highly attenuated mutants and characterize their defects in virulence. Our study shows that small differences in the virulence of P. aeruginosa , such as those caused by deleting the gene encoding a single virulence factor, may not be detectable in the G. mellonella model of infection. This is an important finding for researchers considering the choice of model organisms for virulence studies.
- 1 July 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (7) , e0281124
Open Accesspiv does not impact Pseudomonas aeruginosa virulence in Galleria mellonella
Pseudomonas aeruginosa is an opportunistic human pathogen that can also infect mammals, invertebrates, and plants. Protease IV (PIV) is a secreted protease shown to be important in mammalian cornea, lung, and wound models of infection. It also contributes to P. aeruginosa virulence in many invertebrate models. Previous studies have shown that the expression of the gene encoding PIV is higher at 25°C than at 37°C. Thus, we hypothesized that piv would be more important for P. aeruginosa virulence at 25°C than at 37°C. To test this, we first demonstrated that more PIV is secreted by P. aeruginosa PAO1 cells grown at 25°C than at 37°C. We then determined the survival of larvae of the greater wax moth Galleria mellonella infected by PAO1 and an isogenic Δ piv mutant at both 25°C and 37°C. We found no significant difference in virulence between PAO1 and Δ piv at either 25°C or 37°C, although both strains were more virulent at 37°C than 25°C as measured by a decrease in median survival time. P. aeruginosa possesses an arsenal of virulence factors besides PIV, and thus loss of this single virulence factor may not result in attenuation in the highly susceptible G. mellonella larvae. IMPORTANCE: Pathogenesis of the important opportunistic pathogen Pseudomonas aeruginosa is often investigated using model organisms. Larvae of the greater wax moth, Galleria mellonella , are a popular non-mammalian model organism for P. aeruginosa infections that have been used to study highly attenuated mutants and characterize their defects in virulence. Our study shows that small differences in the virulence of P. aeruginosa , such as those caused by deleting the gene encoding a single virulence factor, may not be detectable in the G. mellonella model of infection. This is an important finding for researchers considering the choice of model organisms for virulence studies.
- Open Access
- 7 January 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (1) , e0151324
RNA-seq reproducibility of Pseudomonas aeruginosa in laboratory models of cystic fibrosis
Reproducibility is a fundamental expectation in science and enables investigators to have confidence in their research findings and the ability to compare data from disparate sources, but evaluating reproducibility can be elusive. For example, generating RNA sequencing (RNA-seq) data includes multiple steps where variance can be introduced. Thus, it is unclear if RNA-seq data from different sources can be validly compared. While most studies on RNA-seq reproducibility focus on eukaryotes, we evaluate bias in bacteria using Pseudomonas aeruginosa gene expression data from five laboratory models of cystic fibrosis. We leverage a large data set that includes samples prepared in three different laboratories and paired data sets where the same sample was sequenced using at least two different sequencing pipelines. We report here that expression data are highly reproducible across laboratories. In addition, while samples sequenced with different sequencing pipelines showed significantly more variance in expression profiles than between labs, gene expression was still highly reproducible between sequencing pipelines. Further investigation of expression differences between two sequencing pipelines revealed that library preparation methods were the largest source of error, though analyses to identify the source of this variance were inconclusive. Consistent with the reproducibility of expression between sequencing pipelines, we found that different pipelines detected over 80% of the same differentially expressed genes with large expression differences between conditions. Thus, bacterial RNA-seq data from different sources can be validly compared, facilitating the ability to advance understanding of bacterial behavior and physiology using the wide array of publicly available RNA-seq data sets. IMPORTANCE: RNA sequencing (RNA-seq) has revolutionized biology, but many steps in RNA-seq workflows can introduce variance, potentially compromising reproducibility. While reproducibility in RNA-seq has been thoroughly investigated in eukaryotes, less is known about pipelines and workflows that introduce variance and biases in bacterial RNA-seq data. By leveraging Pseudomonas aeruginosa transcriptomes in cystic fibrosis models from different laboratories and sequenced with different sequencing pipelines, we directly assess sources of bacterial RNA-seq variance. RNA-seq data were highly reproducible, with the largest variance due to sequencing pipelines, specifically library preparation. Different sequencing pipelines detected overlapping differentially expressed genes, especially those with large expression differences between conditions. This study confirms that different approaches to preparing and sequencing bacterial RNA libraries capture comparable transcriptional profiles, supporting investigators’ ability to leverage diverse RNA-seq data sets to advance their science.
- 7 January 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (1) , e0151324
Open AccessRNA-seq reproducibility of Pseudomonas aeruginosa in laboratory models of cystic fibrosis
Reproducibility is a fundamental expectation in science and enables investigators to have confidence in their research findings and the ability to compare data from disparate sources, but evaluating reproducibility can be elusive. For example, generating RNA sequencing (RNA-seq) data includes multiple steps where variance can be introduced. Thus, it is unclear if RNA-seq data from different sources can be validly compared. While most studies on RNA-seq reproducibility focus on eukaryotes, we evaluate bias in bacteria using Pseudomonas aeruginosa gene expression data from five laboratory models of cystic fibrosis. We leverage a large data set that includes samples prepared in three different laboratories and paired data sets where the same sample was sequenced using at least two different sequencing pipelines. We report here that expression data are highly reproducible across laboratories. In addition, while samples sequenced with different sequencing pipelines showed significantly more variance in expression profiles than between labs, gene expression was still highly reproducible between sequencing pipelines. Further investigation of expression differences between two sequencing pipelines revealed that library preparation methods were the largest source of error, though analyses to identify the source of this variance were inconclusive. Consistent with the reproducibility of expression between sequencing pipelines, we found that different pipelines detected over 80% of the same differentially expressed genes with large expression differences between conditions. Thus, bacterial RNA-seq data from different sources can be validly compared, facilitating the ability to advance understanding of bacterial behavior and physiology using the wide array of publicly available RNA-seq data sets. IMPORTANCE: RNA sequencing (RNA-seq) has revolutionized biology, but many steps in RNA-seq workflows can introduce variance, potentially compromising reproducibility. While reproducibility in RNA-seq has been thoroughly investigated in eukaryotes, less is known about pipelines and workflows that introduce variance and biases in bacterial RNA-seq data. By leveraging Pseudomonas aeruginosa transcriptomes in cystic fibrosis models from different laboratories and sequenced with different sequencing pipelines, we directly assess sources of bacterial RNA-seq variance. RNA-seq data were highly reproducible, with the largest variance due to sequencing pipelines, specifically library preparation. Different sequencing pipelines detected overlapping differentially expressed genes, especially those with large expression differences between conditions. This study confirms that different approaches to preparing and sequencing bacterial RNA libraries capture comparable transcriptional profiles, supporting investigators’ ability to leverage diverse RNA-seq data sets to advance their science.
- Open Access
- 5 November 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (11) , e0053024
Characterization of Pseudomonas aeruginosa from subjects with diffuse panbronchiolitis
Diffuse panbronchiolitis (DPB) is a rare, idiopathic inflammatory disease primarily diagnosed in East Asian populations. DPB is characterized by diffuse pulmonary lesions, inflammation of the respiratory bronchioles, and bacterial infections of the airway. Historically, sputum cultures reveal Pseudomonas aeruginosa in 22% of DPB patients, increasing to 60% after 4 years from disease onset. Although DPB patients have a known susceptibility to respiratory P. aeruginosa infections, as is observed in other chronic lung diseases such as cystic fibrosis (CF), the characterization of DPB P. aeruginosa strains is limited. In this study, we characterized 24 strains obtained from a cohort of DPB patients for traits previously associated with virulence, including growth, motility, antibiotic susceptibility, lipopolysaccharide structure, and genomic diversity. Our cohort of DPB P. aeruginosa strains exhibits considerable genomic variability when compared with isolates from people with cystic fibrosis chronically colonized with P. aeruginosa and acute P. aeruginosa infection isolates. Similar to CF, DPB P. aeruginosa strains produce a diverse array of modified lipid A structures. Antibiotic susceptibility testing revealed increased resistance to erythromycin, a representative agent of the macrolide antibiotics used to manage DPB patients. Differences in the O-antigen type among P. aeruginosa strains collected from these different backgrounds were also observed. Ultimately, the characterization of DPB P. aeruginosa strains highlights several unique qualities of P. aeruginosa strains collected from chronically diseased airways, underscoring the challenges in treating DPB, CF, and other obstructive respiratory disease patients with P. aeruginosa infections. IMPORTANCE: Diffuse panbronchiolitis (DPB), a chronic lung disease characterized by persistent P. aeruginosa infection, serves as an informative comparator to more common chronic lung diseases, such as cystic fibrosis (CF). This study aimed to better address the interplay between P. aeruginosa and chronically compromised airway environments through the examination of DPB P. aeruginosa strains, as existing literature regarding DPB is limited to case reports, case series, and clinical treatment guidelines. The evaluation of these features in the context of DPB, in tandem with prevailing knowledge of P. aeruginosa strains collected from more common chronic lung diseases (e.g., CF), can aid in the development of more effective strategies to combat respiratory P. aeruginosa infections in patients with chronic lung diseases.
- 5 November 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (11) , e0053024
Open AccessCharacterization of Pseudomonas aeruginosa from subjects with diffuse panbronchiolitis
Diffuse panbronchiolitis (DPB) is a rare, idiopathic inflammatory disease primarily diagnosed in East Asian populations. DPB is characterized by diffuse pulmonary lesions, inflammation of the respiratory bronchioles, and bacterial infections of the airway. Historically, sputum cultures reveal Pseudomonas aeruginosa in 22% of DPB patients, increasing to 60% after 4 years from disease onset. Although DPB patients have a known susceptibility to respiratory P. aeruginosa infections, as is observed in other chronic lung diseases such as cystic fibrosis (CF), the characterization of DPB P. aeruginosa strains is limited. In this study, we characterized 24 strains obtained from a cohort of DPB patients for traits previously associated with virulence, including growth, motility, antibiotic susceptibility, lipopolysaccharide structure, and genomic diversity. Our cohort of DPB P. aeruginosa strains exhibits considerable genomic variability when compared with isolates from people with cystic fibrosis chronically colonized with P. aeruginosa and acute P. aeruginosa infection isolates. Similar to CF, DPB P. aeruginosa strains produce a diverse array of modified lipid A structures. Antibiotic susceptibility testing revealed increased resistance to erythromycin, a representative agent of the macrolide antibiotics used to manage DPB patients. Differences in the O-antigen type among P. aeruginosa strains collected from these different backgrounds were also observed. Ultimately, the characterization of DPB P. aeruginosa strains highlights several unique qualities of P. aeruginosa strains collected from chronically diseased airways, underscoring the challenges in treating DPB, CF, and other obstructive respiratory disease patients with P. aeruginosa infections. IMPORTANCE: Diffuse panbronchiolitis (DPB), a chronic lung disease characterized by persistent P. aeruginosa infection, serves as an informative comparator to more common chronic lung diseases, such as cystic fibrosis (CF). This study aimed to better address the interplay between P. aeruginosa and chronically compromised airway environments through the examination of DPB P. aeruginosa strains, as existing literature regarding DPB is limited to case reports, case series, and clinical treatment guidelines. The evaluation of these features in the context of DPB, in tandem with prevailing knowledge of P. aeruginosa strains collected from more common chronic lung diseases (e.g., CF), can aid in the development of more effective strategies to combat respiratory P. aeruginosa infections in patients with chronic lung diseases.
- Open Access
Loss of O-specific antigen shapes Pseudomonas aeruginosa population microbiogeography in murine preclinical pulmonary infection model
Chronic Pseudomonas aeruginosa infections are the hallmark of late-stage lung disease in individuals with cystic fibrosis. During chronic infection P. aeruginosa becomes the dominant bacteria in the airway. Within-host adaptation of P. aeruginosa leads to vast phenotypic and genetic population heterogeneity. In vitro studies show mutations in lipopolysaccharide (LPS) O-specific antigen changes the aggregate formation in P. aeruginosa , however role of these changes in aggregate assembly in vivo is not understood. Using a synthetic CF sputum media and a preclinical murine infection model we assessed how the PAO1 wildtype and O-specific antigen mutants interact with each other, and if P. aeruginosa population heterogeneity affects the colonization of the murine lungs. Our findings suggest that the presence of variants lacking O-specific antigen does not impact the population fitness and size in both in vitro and in vivo , however it can influence the aggregate volume in vivo .
Open AccessLoss of O-specific antigen shapes Pseudomonas aeruginosa population microbiogeography in murine preclinical pulmonary infection model
Chronic Pseudomonas aeruginosa infections are the hallmark of late-stage lung disease in individuals with cystic fibrosis. During chronic infection P. aeruginosa becomes the dominant bacteria in the airway. Within-host adaptation of P. aeruginosa leads to vast phenotypic and genetic population heterogeneity. In vitro studies show mutations in lipopolysaccharide (LPS) O-specific antigen changes the aggregate formation in P. aeruginosa , however role of these changes in aggregate assembly in vivo is not understood. Using a synthetic CF sputum media and a preclinical murine infection model we assessed how the PAO1 wildtype and O-specific antigen mutants interact with each other, and if P. aeruginosa population heterogeneity affects the colonization of the murine lungs. Our findings suggest that the presence of variants lacking O-specific antigen does not impact the population fitness and size in both in vitro and in vivo , however it can influence the aggregate volume in vivo .
- Open Access
- 3 October 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (10) , e0132524
Flagellum-deficient Pseudomonas aeruginosa is more virulent than non-motile but flagellated mutants in a cystic fibrosis mouse model
Loss of the flagellum marks the pathoadaptation of Pseudomonas aeruginosa to the cystic fibrosis (CF) airway environment during lung disease. Losing the flagellum is advantageous to the bacterium as the flagellum can be recognized by immune cells. The primary purpose of the flagellum is, however, to provide motility to the bacterium. Our goal was to determine whether the loss of flagellar motility or the loss of flagellum expression contributes to P. aeruginosa lung infection in CF. To address this, wild-type and gut-corrected FABP-human cystic fibrosis transmembrane conductance regulator (hCFTR) mice deficient in the murine Cftr gene were infected intratracheally with lethal doses of wild-type or flagellum-deficient P. aeruginosa . While there was no significant difference in the survival of wild-type mice after infection with either of the bacterial strains, a significantly higher mortality was observed in FABP-hCFTR mice infected with flagellum-deficient P. aeruginosa , compared to mice infected with their flagellated counterparts. When FABP-hCFTR mice were infected with isogenic, motility-deficient flagellated mutants, animal survival and lung bacterial titers were similar to those observed in mice infected with the wild-type bacterium. Airway levels of neutrophils and the amount neutrophil elastase were similar in mice infected with either the wild-type bacteria or the flagellum-deficient P. aeruginosa . Our results show that FABP-hCFTR mice have a different response to flagellum loss in P. aeruginosa compared to wild-type animals. The loss of flagellum expression, rather than the loss of motility, is the main driver behind the increased virulence of flagellum-deficient P. aeruginosa in CF. These observations provide new insight into P. aeruginosa virulence in CF. IMPORTANCE: Pseudomonas aeruginosa , a major respiratory pathogen in cystic fibrosis, is known to lose its flagellum during the course of infection in the airways. Here, we show that the loss of flagellum leads to a more enhanced virulence in Cftr-deficient cystic fibrosis mice than in control animals. Loss of flagellum expression, rather than the loss of flagellar swimming motility, represents the main driver behind this increased virulence suggesting that this appendage plays a specific role in P. aeruginosa virulence in cystic fibrosis airways.
- 3 October 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (10) , e0132524
Open AccessFlagellum-deficient Pseudomonas aeruginosa is more virulent than non-motile but flagellated mutants in a cystic fibrosis mouse model
Loss of the flagellum marks the pathoadaptation of Pseudomonas aeruginosa to the cystic fibrosis (CF) airway environment during lung disease. Losing the flagellum is advantageous to the bacterium as the flagellum can be recognized by immune cells. The primary purpose of the flagellum is, however, to provide motility to the bacterium. Our goal was to determine whether the loss of flagellar motility or the loss of flagellum expression contributes to P. aeruginosa lung infection in CF. To address this, wild-type and gut-corrected FABP-human cystic fibrosis transmembrane conductance regulator (hCFTR) mice deficient in the murine Cftr gene were infected intratracheally with lethal doses of wild-type or flagellum-deficient P. aeruginosa . While there was no significant difference in the survival of wild-type mice after infection with either of the bacterial strains, a significantly higher mortality was observed in FABP-hCFTR mice infected with flagellum-deficient P. aeruginosa , compared to mice infected with their flagellated counterparts. When FABP-hCFTR mice were infected with isogenic, motility-deficient flagellated mutants, animal survival and lung bacterial titers were similar to those observed in mice infected with the wild-type bacterium. Airway levels of neutrophils and the amount neutrophil elastase were similar in mice infected with either the wild-type bacteria or the flagellum-deficient P. aeruginosa . Our results show that FABP-hCFTR mice have a different response to flagellum loss in P. aeruginosa compared to wild-type animals. The loss of flagellum expression, rather than the loss of motility, is the main driver behind the increased virulence of flagellum-deficient P. aeruginosa in CF. These observations provide new insight into P. aeruginosa virulence in CF. IMPORTANCE: Pseudomonas aeruginosa , a major respiratory pathogen in cystic fibrosis, is known to lose its flagellum during the course of infection in the airways. Here, we show that the loss of flagellum leads to a more enhanced virulence in Cftr-deficient cystic fibrosis mice than in control animals. Loss of flagellum expression, rather than the loss of flagellar swimming motility, represents the main driver behind this increased virulence suggesting that this appendage plays a specific role in P. aeruginosa virulence in cystic fibrosis airways.
- Open Access
- 5 August 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (33)
Improvement of a mouse infection model to capture Pseudomonas aeruginosa chronic physiology in cystic fibrosis
Laboratory models are central to microbiology research, advancing the understanding of bacterial physiology by mimicking natural environments, from soil to the human microbiome. When studying host–bacteria interactions, animal models enable investigators to examine bacterial dynamics associated with a host, and in the case of human infections, animal models are necessary to translate basic research into clinical treatments. Efforts toward improving animal infection models are typically based on reproducing host genotypes/phenotypes and disease manifestations, leaving a gap in how well the physiology of microbes reflects their behavior in a human host. Understanding bacterial physiology is vital because it dictates host response and bacterial interactions with antimicrobials. Thus, our goal was to develop an animal model that accurately recapitulates bacterial physiology in human infection. The system we chose to model was a chronic Pseudomonas aeruginosa respiratory infection in cystic fibrosis (CF). To accomplish this goal, we leveraged a framework that we recently developed to evaluate model accuracy by calculating the percentage of bacterial genes that are expressed similarly in a model to how they are expressed in their infection environment. We combined two complementary models of P. aeruginosa infection—an in vitro synthetic CF sputum model (SCFM2) and a mouse acute pneumonia model. This combined model captured the chronic physiology of P. aeruginosa in CF better than the standard mouse infection model, showing the power of a data-driven approach to refining animal models. In addition, the results of this work challenge the assumption that a chronic infection model requires long-term colonization.
- 5 August 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (33)
Open AccessImprovement of a mouse infection model to capture Pseudomonas aeruginosa chronic physiology in cystic fibrosis
Laboratory models are central to microbiology research, advancing the understanding of bacterial physiology by mimicking natural environments, from soil to the human microbiome. When studying host–bacteria interactions, animal models enable investigators to examine bacterial dynamics associated with a host, and in the case of human infections, animal models are necessary to translate basic research into clinical treatments. Efforts toward improving animal infection models are typically based on reproducing host genotypes/phenotypes and disease manifestations, leaving a gap in how well the physiology of microbes reflects their behavior in a human host. Understanding bacterial physiology is vital because it dictates host response and bacterial interactions with antimicrobials. Thus, our goal was to develop an animal model that accurately recapitulates bacterial physiology in human infection. The system we chose to model was a chronic Pseudomonas aeruginosa respiratory infection in cystic fibrosis (CF). To accomplish this goal, we leveraged a framework that we recently developed to evaluate model accuracy by calculating the percentage of bacterial genes that are expressed similarly in a model to how they are expressed in their infection environment. We combined two complementary models of P. aeruginosa infection—an in vitro synthetic CF sputum model (SCFM2) and a mouse acute pneumonia model. This combined model captured the chronic physiology of P. aeruginosa in CF better than the standard mouse infection model, showing the power of a data-driven approach to refining animal models. In addition, the results of this work challenge the assumption that a chronic infection model requires long-term colonization.
- Open Access
- 2 July 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (7) , e0041024
Mutation of hmgA , encoding homogentisate 1,2-dioxygenase, is responsible for pyomelanin production but does not impact the virulence of Burkholderia cenocepacia in a chronic granulomatous disease mouse lung infection
The Burkholderia cepacia complex (Bcc) is a group of Gram-negative opportunistic bacteria often associated with fatal pulmonary infections in patients with impaired immunity, particularly those with cystic fibrosis (CF) and chronic granulomatous disease (CGD). Some Bcc strains are known to naturally produce pyomelanin, a brown melanin-like pigment known for scavenging free radicals; pigment production has been reported to enable Bcc strains to overcome the host cell oxidative burst. In this work, we investigated the role of pyomelanin in resistance to oxidative stress and virulence in strains J2315 and K56-2, two epidemic CF isolates belonging to the Burkholderia cenocepacia ET-12 lineage. We previously reported that a single amino acid change from glycine to arginine at residue 378 in homogentisate 1,2-dioxygenase (HmgA) affects the pigment production phenotype: pigmented J2315 has an arginine at position 378, while non-pigmented K56-2 has a glycine at this position. Herein, we performed allelic exchange to generate isogenic non-pigmented and pigmented strains of J2315 and K56-2, respectively, and tested these to determine whether pyomelanin contributes to the protection against oxidative stress in vitro as well as in a respiratory infection in CGD mice in vivo . Our results indicate that the altered pigment phenotype does not significantly impact these strains’ ability to resist oxidative stress with H 2 O 2 and NO in vitro and did not change the virulence and infection outcome in CGD mice in vivo suggesting that other factors besides pyomelanin are contributing to the pathophysiology of these strains. IMPORTANCE: The Burkholderia cepacia complex (Bcc) is a group of Gram-negative opportunistic bacteria that are often associated with fatal pulmonary infections in patients with impaired immunity, particularly those with cystic fibrosis and chronic granulomatous disease (CGD). Some Bcc strains are known to naturally produce pyomelanin, a brown melanin-like pigment known for scavenging free radicals and overcoming the host cell oxidative burst. We investigated the role of pyomelanin in Burkholderia cenocepacia strains J2315 (pigmented) and K56-2 (non-pigmented) and performed allelic exchange to generate isogenic non-pigmented and pigmented strains, respectively. Our results indicate that the altered pigment phenotype does not significantly impact these strains’ ability to resist H 2 O 2 or NO in vitro and did not alter the outcome of a respiratory infection in CGD mice in vivo . These results suggest that pyomelanin may not always constitute a virulence factor and suggest that other features are contributing to the pathophysiology of these strains.
- 2 July 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (7) , e0041024
Open AccessMutation of hmgA , encoding homogentisate 1,2-dioxygenase, is responsible for pyomelanin production but does not impact the virulence of Burkholderia cenocepacia in a chronic granulomatous disease mouse lung infection
The Burkholderia cepacia complex (Bcc) is a group of Gram-negative opportunistic bacteria often associated with fatal pulmonary infections in patients with impaired immunity, particularly those with cystic fibrosis (CF) and chronic granulomatous disease (CGD). Some Bcc strains are known to naturally produce pyomelanin, a brown melanin-like pigment known for scavenging free radicals; pigment production has been reported to enable Bcc strains to overcome the host cell oxidative burst. In this work, we investigated the role of pyomelanin in resistance to oxidative stress and virulence in strains J2315 and K56-2, two epidemic CF isolates belonging to the Burkholderia cenocepacia ET-12 lineage. We previously reported that a single amino acid change from glycine to arginine at residue 378 in homogentisate 1,2-dioxygenase (HmgA) affects the pigment production phenotype: pigmented J2315 has an arginine at position 378, while non-pigmented K56-2 has a glycine at this position. Herein, we performed allelic exchange to generate isogenic non-pigmented and pigmented strains of J2315 and K56-2, respectively, and tested these to determine whether pyomelanin contributes to the protection against oxidative stress in vitro as well as in a respiratory infection in CGD mice in vivo . Our results indicate that the altered pigment phenotype does not significantly impact these strains’ ability to resist oxidative stress with H 2 O 2 and NO in vitro and did not change the virulence and infection outcome in CGD mice in vivo suggesting that other factors besides pyomelanin are contributing to the pathophysiology of these strains. IMPORTANCE: The Burkholderia cepacia complex (Bcc) is a group of Gram-negative opportunistic bacteria that are often associated with fatal pulmonary infections in patients with impaired immunity, particularly those with cystic fibrosis and chronic granulomatous disease (CGD). Some Bcc strains are known to naturally produce pyomelanin, a brown melanin-like pigment known for scavenging free radicals and overcoming the host cell oxidative burst. We investigated the role of pyomelanin in Burkholderia cenocepacia strains J2315 (pigmented) and K56-2 (non-pigmented) and performed allelic exchange to generate isogenic non-pigmented and pigmented strains, respectively. Our results indicate that the altered pigment phenotype does not significantly impact these strains’ ability to resist H 2 O 2 or NO in vitro and did not alter the outcome of a respiratory infection in CGD mice in vivo . These results suggest that pyomelanin may not always constitute a virulence factor and suggest that other features are contributing to the pathophysiology of these strains.